Showing results (1-10 of 695) with videos related to
Sort By:
Pageof 70
Oncology|January 1, 1985
Acute leukemia secondary to lung cancer. Case report and review of the literatureA de Gramont, E Rioux, P Fortin, et al.Cancer|February 1, 1985
Erythrocyte mean corpuscular volume during cytotoxic therapy and the risk of secondary leukemiaA de Gramont, E Rioux, Y Drolet, et al.Cancer Treatment Reports|December 1, 1984
Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's diseaseA de Gramont, E Rioux, Y Drolet, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 29, 1984
[Changes in the mean corpuscular volume during the cytotoxic treatment of cancer and risk of secondary leukemia. Preliminary results]A de Gramont, E Rioux, Y Drolet, et al.La Revue De Medecine Interne|January 1, 1997
[Role and value of oxaliplatin in metastatic colorectal cancers]C Louvet, A de GramontSeminars in Oncology|June 3, 1998
Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancerH Bleiberg, A de GramontCancer|January 15, 1987
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's diseaseA de Gramont, C Louvet, M Krulik, et al.The Journal of Infusional Chemotherapy|July 1, 1996
The French experience with infusional 5-fluorouracil in advanced colorectal cancerA de Gramont, C Louvet, M KrulikEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 1997
Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinomaE Raymond, Y Drolet, L Marpeau, et al.Pageof 70